| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 10/09/2001 | US6299859 Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them |
| 10/09/2001 | US6299858 Contacting living teleost post 12-hours of development with dye having affinity for dead cells and stains dead cells; administering agent to living teleost; detecting staining of dead cells with dye in specific tissue or organ; comparing |
| 10/04/2001 | WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer |
| 10/04/2001 | WO2001072680A1 Substituted chalcones as therapeutic compounds |
| 10/04/2001 | WO2001072342A1 Gastric emptying test-kit and method of testing gastric emptying of solid meal |
| 10/04/2001 | WO2001072301A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 10/04/2001 | WO2001072281A2 Microspheres for active embolization |
| 10/04/2001 | WO2001072217A1 Measuring cognitive impairment |
| 10/04/2001 | WO2001032070A3 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 10/04/2001 | WO2001013957A3 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 10/04/2001 | US20010027265 Method and apparatus for imaging abdominal aorta and aortic aneurysms |
| 10/04/2001 | US20010027172 Made by decarboxylation of the corresponding fluoroalkyl ether carboxylic acids; use in fluorinated polyether deposition, soldering, and cleaning and drying; low boiling, shorter atomospheric life, less harmful to ozone layer |
| 10/04/2001 | US20010025493 Hyperpolarized gas containers, solenoids, transport and storage devices and associated transport and storage methods |
| 10/04/2001 | EP1139268A2 Measuring cognitive impairment due to incidental or intentional exposure to neurotoxic elements |
| 10/04/2001 | EP1139109A1 A method for magnetic resonance imaging of the lung |
| 10/04/2001 | EP1137766A1 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 10/04/2001 | EP1137443A1 Magnetic resonance tomography contrast agent |
| 10/04/2001 | EP0529002B1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
| 10/04/2001 | CA2403751A1 Measuring cognitive impairment |
| 10/04/2001 | CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease |
| 10/03/2001 | CN1072019C Contrast medium capable of eliminating in-stomach fluid level false shadow in CT scanning |
| 10/02/2001 | US6296833 Administering compound that binds with specificity to a calcium-sensing receptor (car) and that is labeled with an agent that allows compound to be detected using in vivo imaging techniques; comparing; determining abnormal growth |
| 10/02/2001 | US6296832 Molecular medicine and drug delivery; in vivo panning for identifying molecule that homes to a specific organ |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | WO2001070735A1 Heteroaromatic compounds having two-photon absorption activity |
| 09/27/2001 | WO2001070291A2 Injectable microspheres for dermal augmentation and tissue bulking |
| 09/27/2001 | WO2001070102A2 Meted hyperpolarized noble gas dispensing methods and associated devices |
| 09/27/2001 | WO2001030754A3 Micro-cluster liquids and methods of making and using them |
| 09/27/2001 | WO2001016176A3 Transgenic animal model for neurodegenerative diseases |
| 09/27/2001 | WO2001008711A3 Stable microbubbles for the use as an ultrasound contrast agent |
| 09/27/2001 | US20010025144 Gas filled liposomes and their use as ultrasonic contrast agents |
| 09/27/2001 | US20010024795 Detecting very low concentration of a molecule by contacting a sample with a multispecific molecule capable of binding the molecule to be detected forming a complex, which is then bound by another molecule linked by a polymer to many signals |
| 09/27/2001 | US20010024650 Artery - and vein-specific proteins and uses therefor |
| 09/27/2001 | US20010024640 An ultrasound contrast agent comprising a suspension containing a film forming surfactant which is phospholipid and a freon gas filled microbubbles in a physiologically compatible aqueous carrier; used in ultrasonic echography |
| 09/27/2001 | US20010024639 Administering to a patient a contrast medium comprising a homogenous aqueous suspension of low density polymeric microsphere filled with a gas, scanning the patient using computed tomography imaging to obtain visible image of tissue |
| 09/27/2001 | US20010024638 An ultrasound contrast agent comprising an aqueous suspension of gas filled microbubbles comprising a saturated phospholipid, a fatty acid, a polyoxyethylene hydrophilic stabilizer and sulfur hexafluoride |
| 09/27/2001 | DE10012120A1 New ligand, comprising therapeutic or diagnostic agent bonded non-covalently with substance having high affinity to transport molecule |
| 09/27/2001 | CA2403572A1 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402564A1 Heteroaromatic compounds having two-photon absorption activity |
| 09/26/2001 | EP1135677A1 In vivo biosensor apparatus and method of use |
| 09/26/2001 | EP1135531A1 Methods for introducing heterologous cells into fish |
| 09/26/2001 | EP1135170A2 Radioconjugation of internalizing antibodies |
| 09/26/2001 | EP0831931A4 An in vivo and in vitro model of cutaneous photoaging |
| 09/26/2001 | EP0528991B1 Detectably labelled marker component comprising a fluorophore moiety , fluorescent probe comprising the marker component and uses thereof. |
| 09/26/2001 | CN1314430A Nanometer microball of chitosan-polyacrylic acid composite and its producing method and use |
| 09/26/2001 | CN1314185A Tissue anoxia developing agent and its precursor |
| 09/26/2001 | CN1071580C 造影剂 Contrast agents |
| 09/25/2001 | US6294340 Method of binding material to the β-amyloid peptide |
| 09/25/2001 | US6294152 Complexes of 1-substituted-3-hydoxy-2-alkyl-4-pyridinone ligands, |
| 09/25/2001 | US6294151 Diagnosing the infection with urease-generating bacteria, particularly helicobacter pylori. |
| 09/20/2001 | WO2001069252A1 Methods and compositions for the regulation of vasoconstriction |
| 09/20/2001 | WO2001069244A2 Method for labeling individual cells |
| 09/20/2001 | WO2001069199A2 Methods of detecting cancer using cellular autofluorescence |
| 09/20/2001 | WO2001068722A1 Hydrogel biomedical articles |
| 09/20/2001 | WO2001068721A1 Tissue bulking and coating compositions |
| 09/20/2001 | WO2001068720A1 Embolic compositions |
| 09/20/2001 | WO2001068700A2 Regulation of human substance p-like g protein-coupled receptor |
| 09/20/2001 | WO2001068679A2 Peptides targeting specifically tumor-derived endothelial cells |
| 09/20/2001 | WO2001068151A2 Functional radiographic imaging methods and agents |
| 09/20/2001 | WO2001068150A1 Microcapsules comprising functionalised polyalkylcyanoacrylates |
| 09/20/2001 | WO2001068142A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 09/20/2001 | WO2001067955A2 Diagnostic procedures using direct injection of gaseous hyperpolarized 129xe and associated systems and products |
| 09/20/2001 | WO2000047111A9 Ph sensitive mri contrast agents |
| 09/20/2001 | US20010023247 Photodynamic therapy |
| 09/20/2001 | US20010022970 Halogenated xanthan compound |
| 09/20/2001 | US20010022963 Light imaging contrast agents |
| 09/20/2001 | US20010022962 Cellulose diacetate compositions for use in embolizing blood vessels |
| 09/20/2001 | DE10013850A1 Gas-filled microcapsules, useful for ultrasonic diagnosis, are prepared from functionalized poly(alkyl cyanoacrylate), allowing attachment of e.g. specific-binding agents |
| 09/20/2001 | DE10002939C1 New aromatic-substituted tetraazacyclododecane-triacetic acid paramagnetic metal complex compounds, are useful as contrast agents for magnetic resonance imaging of necrotic or infarction tissue |
| 09/20/2001 | CA2403220A1 Methods and compositions for the regulation of vasoconstriction |
| 09/20/2001 | CA2402327A1 Peptides targeting specifically tumor-derived endothelial cells |
| 09/20/2001 | CA2402233A1 Methods of detecting cancer using cellular autofluorescence |
| 09/20/2001 | CA2401308A1 Diagnostic procedures using direct injection of gaseous hyperpolarized 129xe and associated systems and products |
| 09/20/2001 | CA2401270A1 Method for labeling individual cells |
| 09/20/2001 | CA2400906A1 Microcapsules comprising functionalised polyalkylcyanoacrylates |
| 09/19/2001 | EP1133494A1 8-azabicyclo 3.2.1]oct-2-ene and -octane derivatives |
| 09/19/2001 | EP1133310A2 Artery- and vein-specific proteins and uses therefor |
| 09/19/2001 | EP0744961B1 Gas-containing microparticles, agents containing them, their use in medical diagnosis by ultrasonic techniques and methods of producing said particles and agents |
| 09/19/2001 | CN1313856A Thiazoline acid derivatives |
| 09/19/2001 | CN1313762A Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 09/13/2001 | WO2001066784A1 Inhibitor of differentiation knockout mammals and methods of use thereof |
| 09/13/2001 | WO2001066156A2 Use of radiopharmaceuticals and intraoperative radiation probe |
| 09/13/2001 | WO2001066153A1 Fluorescent membrane intercalating probes and methods for their use |
| 09/13/2001 | WO2001066152A1 Simultaneous multimodal measurement of physiological function |
| 09/13/2001 | WO2001066030A1 Methods and apparatus for optical imaging |
| 09/13/2001 | WO2001066016A1 Embolic agents visible under ultrasound |
| 09/13/2001 | WO2001065998A2 Methods for the diagnosis and treatment of breast cancer |
| 09/13/2001 | WO2001026635A3 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 09/13/2001 | WO2000038579A9 Device and method for safe location and marking of a cavity and sentinel lymph nodes |
| 09/13/2001 | US20010021371 Ultrasonic images using contrast agent |
| 09/13/2001 | US20010020475 Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug |
| 09/13/2001 | CA2401879A1 Embolic agents visible under ultrasound |
| 09/12/2001 | EP1131280A1 Preparation of 5-amino-isophthalamides |
| 09/12/2001 | EP1131095A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/12/2001 | EP0744962B1 Method of storage of ultrasonic gas suspensions |
| 09/12/2001 | EP0505479B1 Method and device for detecting and quantifying glucose in body fluids |
| 09/12/2001 | CN1312909A Resilent containers for hyperpolarized gases |
| 09/11/2001 | US6288224 Preparation of n-arylmethyl aziridine derivatives, 1,4,7,10-tetraazacyclododecane derivatives obtained therefrom and n-arylethyl-ethanolamine sulphonate esters as intermediates |